1. Home
  2. BRBI vs AVXL Comparison

BRBI vs AVXL Comparison

Compare BRBI & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BRBI BR Partners S.A. ADSs

BRBI

BRBI BR Partners S.A. ADSs

N/A

Current Price

$11.24

Market Cap

295.0M

Sector

Finance

ML Signal

N/A

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

N/A

Current Price

$1.94

Market Cap

237.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BRBI
AVXL
Founded
2009
2004
Country
Brazil
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
295.0M
237.2M
IPO Year
2025
2013

Fundamental Metrics

Financial Performance
Metric
BRBI
AVXL
Price
$11.24
$1.94
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $20.00
AVG Volume (30 Days)
834.0
★ 595.0K
Earning Date
11-06-2026
08-25-2026
Dividend Yield
★ 8.67%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$17.79
N/A
P/E Ratio
$11.72
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.09
$2.26
52 Week High
$16.61
$10.38

Technical Indicators

Market Signals
Indicator
BRBI
AVXL
Relative Strength Index (RSI) 54.78 25.57
Support Level $10.90 N/A
Resistance Level $11.97 $2.80
Average True Range (ATR) 0.11 0.13
MACD 0.25 -0.04
Stochastic Oscillator 94.71 12.67

Price Performance

Historical Comparison
BRBI
AVXL

About BRBI BRBI BR Partners S.A. ADSs

BRBI BR Partners SA, formerly BR Advisory Partners Participacoes SA, is engaged in investing in other companies, domestic or foreign, as a partner, quota holder, or shareholder, and management of its assets. It has a single reportable segment being investment banking services, which are administered and managed according to the products offered. However, the company divides it's operations into the following business lines: (1) investment banking and capital markets, (2) treasury sales & structuring, (3) investments and wealth management and (4) capital remuneration.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: